These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38621963)

  • 21. Gemigliptin Attenuates Renal Fibrosis Through Down-Regulation of the NLRP3 Inflammasome.
    Seo JB; Choi YK; Woo HI; Jung YA; Lee S; Lee S; Park M; Lee IK; Jung GS; Park KG
    Diabetes Metab J; 2019 Dec; 43(6):830-839. PubMed ID: 30877711
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Artificially Cultivated
    Wang C; Hou XX; Rui HL; Li LJ; Zhao J; Yang M; Sun LJ; Dong HR; Cheng H; Chen YP
    J Diabetes Res; 2018; 2018():1390418. PubMed ID: 30534570
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel biphenyl diester derivative AB-38b inhibits NLRP3 inflammasome through Nrf2 activation in diabetic nephropathy.
    Du L; Wang J; Chen Y; Li X; Wang L; Li Y; Jin X; Gu X; Hao M; Zhu X; Yin X; Lu Q
    Cell Biol Toxicol; 2020 Jun; 36(3):243-260. PubMed ID: 31768838
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Omarigliptin ameliorated high glucose-induced nucleotide oligomerization domain-like receptor protein 3 (NLRP3) inflammasome activation through activating adenosine monophosphate-activated protein kinase α (AMPKα) in renal glomerular endothelial cells.
    Li L; Qian K; Sun Y; Zhao Y; Zhou Y; Xue Y; Hong X
    Bioengineered; 2021 Dec; 12(1):4805-4815. PubMed ID: 34338149
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of andrographolide on renal tubulointersticial injury and fibrosis. Evidence of its mechanism of action.
    Liu W; Liang L; Zhang Q; Li Y; Yan S; Tang T; Ren Y; Mo J; Liu F; Chen X; Lan T
    Phytomedicine; 2021 Oct; 91():153650. PubMed ID: 34332282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of the NLRP3 inflammasome in the pathogenesis of diabetic nephropathy.
    Qiu YY; Tang LQ
    Pharmacol Res; 2016 Dec; 114():251-264. PubMed ID: 27826011
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PS-MPs promotes the progression of inflammation and fibrosis in diabetic nephropathy through NLRP3/Caspase-1 and TGF-β1/Smad2/3 signaling pathways.
    Feng L; Chen C; Xiong X; Wang X; Li X; Kuang Q; Wei X; Gao L; Niu X; Li Q; Yang J; Li L; Luo P
    Ecotoxicol Environ Saf; 2024 Mar; 273():116102. PubMed ID: 38382346
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Protective effect of ginsenoside metabolite compound K against diabetic nephropathy by inhibiting NLRP3 inflammasome activation and NF-κB/p38 signaling pathway in high-fat diet/streptozotocin-induced diabetic mice.
    Song W; Wei L; Du Y; Wang Y; Jiang S
    Int Immunopharmacol; 2018 Oct; 63():227-238. PubMed ID: 30107367
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine protects diabetic nephropathy by suppressing epithelial-to-mesenchymal transition involving the inactivation of the NLRP3 inflammasome.
    Ma Z; Zhu L; Wang S; Guo X; Sun B; Wang Q; Chen L
    Ren Fail; 2022 Dec; 44(1):923-932. PubMed ID: 35618411
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting NLRP3 inflammasome as a promising approach for treatment of diabetic nephropathy: Preclinical evidences with therapeutic approaches.
    Ram C; Jha AK; Ghosh A; Gairola S; Syed AM; Murty US; Naidu VGM; Sahu BD
    Eur J Pharmacol; 2020 Oct; 885():173503. PubMed ID: 32858047
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variation in
    Tsetsos F; Roumeliotis A; Tsekmekidou X; Alexouda S; Roumeliotis S; Theodoridis M; Thodis E; Panagoutsos S; Papanas N; Papazoglou D; Kotsa K; Yovos JG; Maltezos E; Passadakis P; Paschou P; Georgitsi M
    Diab Vasc Dis Res; 2020; 17(6):1479164120970892. PubMed ID: 33164551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Electro-Acupuncture Protects Diabetic Nephropathy-Induced Inflammation Through Suppression of NLRP3 Inflammasome in Renal Macrophage Isolation.
    Zhang J; Yang X; Zhang X; Lu D; Guo R
    Endocr Metab Immune Disord Drug Targets; 2021; 21(11):2075-2083. PubMed ID: 33461476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NLRP3 inflammasome negatively regulates podocyte autophagy in diabetic nephropathy.
    Hou Y; Lin S; Qiu J; Sun W; Dong M; Xiang Y; Wang L; Du P
    Biochem Biophys Res Commun; 2020 Jan; 521(3):791-798. PubMed ID: 31703838
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Triptolide protects against podocyte injury in diabetic nephropathy by activating the Nrf2/HO-1 pathway and inhibiting the NLRP3 inflammasome pathway.
    Lv C; Cheng T; Zhang B; Sun K; Lu K
    Ren Fail; 2023 Dec; 45(1):2165103. PubMed ID: 36938748
    [No Abstract]   [Full Text] [Related]  

  • 35. The Prospective Ameliorative Role of Zinc Oxide Nanoparticles in STZ-Induced Diabetic Nephropathy in Rats: Mechanistic Targeting of Autophagy and Regulating Nrf2/TXNIP/NLRP3 Inflammasome Signaling.
    Abd El-Khalik SR; Nasif E; Arakeep HM; Rabah H
    Biol Trace Elem Res; 2022 Apr; 200(4):1677-1687. PubMed ID: 34241775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural products in attenuating renal inflammation
    Wang Y; Sui Z; Wang M; Liu P
    Front Immunol; 2023; 14():1196016. PubMed ID: 37215100
    [TBL] [Abstract][Full Text] [Related]  

  • 37. ChREBP Deficiency Suppresses Renal Inflammation and Fibrosis Via Inhibiting NLRP3 Inflammasome Activation in Diabetic Kidney Disease.
    Chen N; Yang Z; Mu L; Wu M; Song J; Zhou T; Shi Y
    Discov Med; 2022; 33(169):69-83. PubMed ID: 36274225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD36 promotes NLRP3 inflammasome activation via the mtROS pathway in renal tubular epithelial cells of diabetic kidneys.
    Hou Y; Wang Q; Han B; Chen Y; Qiao X; Wang L
    Cell Death Dis; 2021 May; 12(6):523. PubMed ID: 34021126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice.
    Wu M; Han W; Song S; Du Y; Liu C; Chen N; Wu H; Shi Y; Duan H
    Mol Cell Endocrinol; 2018 Dec; 478():115-125. PubMed ID: 30098377
    [TBL] [Abstract][Full Text] [Related]  

  • 40. WTAP-mediated N
    Lan J; Xu B; Shi X; Pan Q; Tao Q
    Cell Mol Biol Lett; 2022 Jun; 27(1):51. PubMed ID: 35761192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.